没有比家更好的地方？发热性中性粒细胞减少症低风险患者的门诊管理 - Suppr

Suppr

超能文献

No place like home? Outpatient management of patients with febrile neutropenia and low risk.

作者信息

Freifeld Alison G, Sepkowitz Kent A

出版信息

J Clin Oncol. 2011 Oct 20;29(30):3952-4. doi: 10.1200/JCO.2011.37.5758. Epub 2011 Sep 19.

DOI:10.1200/JCO.2011.37.5758

PMID:21931028

Abstract

摘要

相似文献

No place like home? Outpatient management of patients with febrile neutropenia and low risk.

J Clin Oncol. 2011 Oct 20;29(30):3952-4. doi: 10.1200/JCO.2011.37.5758. Epub 2011 Sep 19.

Costs of home versus inpatient treatment for fever and neutropenia: analysis of a multicenter randomized trial.

J Clin Oncol. 2011 Oct 20;29(30):3984-9. doi: 10.1200/JCO.2011.35.1247. Epub 2011 Sep 19.

Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial.

J Clin Oncol. 2011 Oct 20;29(30):3977-83. doi: 10.1200/JCO.2011.35.0884. Epub 2011 Sep 19.

Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children.

Value Health. 2003 Mar-Apr;6(2):158-66. doi: 10.1046/j.1524-4733.2003.00219.x.

Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients.

Br J Cancer. 2011 Apr 26;104(9):1377-83. doi: 10.1038/bjc.2011.101. Epub 2011 Apr 5.

Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences.

J Clin Oncol. 2004 Oct 1;22(19):3922-9. doi: 10.1200/JCO.2004.01.077.

Are we finally ready for outpatient management of febrile neutropenia?

Pediatr Blood Cancer. 2007 Nov;49(6):765-6. doi: 10.1002/pbc.21224.

Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.

Pediatr Blood Cancer. 2007 Nov;49(6):786-92. doi: 10.1002/pbc.21179.

Oral antibiotics for febrile patients with neutropenia due to cancer chemotherapy.

N Engl J Med. 2000 Jan 6;342(1):56; author reply 56-8.

Current attitudes for therapy of febrile neutropenia with consideration to cost-effectiveness.

Curr Opin Oncol. 1998 Jul;10(4):284-90. doi: 10.1097/00001622-199807000-00002.

引用本文的文献

Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents.

Support Care Cancer. 2018 May;26(5):1465-1470. doi: 10.1007/s00520-017-3985-0. Epub 2017 Nov 22.

The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score.

Clin Transl Oncol. 2017 Sep;19(9):1084-1090. doi: 10.1007/s12094-017-1644-z. Epub 2017 Mar 13.

Responding to Acute Care Needs of Patients With Cancer: Recent Trends Across Continents.

Oncologist. 2016 Mar;21(3):301-7. doi: 10.1634/theoncologist.2014-0341. Epub 2016 Feb 26.

Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.

Cochrane Database Syst Rev. 2013 Oct 9;2013(10):CD003992. doi: 10.1002/14651858.CD003992.pub3.

Clinical and economic burden of emergency department presentations for neutropenia following outpatient chemotherapy for cancer in Victoria, Australia.

Oncologist. 2012;17(7):998-1004. doi: 10.1634/theoncologist.2011-0456. Epub 2012 Jun 15.

Updated systematic review and meta-analysis of the performance of risk prediction rules in children and young people with febrile neutropenia.

PLoS One. 2012;7(5):e38300. doi: 10.1371/journal.pone.0038300. Epub 2012 May 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验